Provided by Tiger Fintech (Singapore) Pte. Ltd.

Arcturus Therapeutics Ltd.

14.41
+0.46003.30%
Post-market: 14.700.2900+2.01%18:48 EDT
Volume:517.34K
Turnover:7.43M
Market Cap:390.81M
PE:-5.71
High:14.75
Open:14.05
Low:13.74
Close:13.95
Loading ...
Feb 28, 2022

Major Issues Report

8-K - Current report
Feb 17, 2022

Major Issues Report

8-K - Current report
Feb 15, 2022

Beneficial Ownership Change

SC 13G - Statement of acquisition of beneficial ownership by individuals
Feb 14, 2022

Beneficial Ownership Change

SC 13G - Statement of acquisition of beneficial ownership by individuals
Feb 14, 2022

Beneficial Ownership Change

SC 13G - Statement of acquisition of beneficial ownership by individuals
Feb 11, 2022

Major Issues Report

8-K - Current report
Feb 09, 2022

Beneficial Ownership Change

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
Feb 04, 2022

Beneficial Ownership Change

SC 13G - Statement of acquisition of beneficial ownership by individuals
Jan 11, 2022

Major Issues Report

8-K - Current report
Dec 13, 2021

Major Issues Report

8-K - Current report
Nov 03, 2021

Statement Of Changes In Beneficial Ownership

4 - Statement of changes in beneficial ownership of securities
Oct 04, 2021

Statement Of Changes In Beneficial Ownership

4 - Statement of changes in beneficial ownership of securities
Aug 26, 2021

Major Issues Report

Arcturus Therapeutics Holdings Inc.
Aug 26, 2021

Major Issues Report

8-K - Current report
Aug 12, 2021

Beneficial Ownership Change

SC 13D/A [Amend] - General statement of acquisition of beneficial ownership
Aug 10, 2021

Quarterly Report

10-Q - Quarterly report [Sections 13 or 15(d)]
Aug 09, 2021

Major Issues Report

8-K - Current report
Aug 04, 2021

Major Issues Report

8-K - Current report
Jun 22, 2021

Major Issues Report

8-K - Current report
May 10, 2021

Major Issues Report

8-K - Current report